Biotechnology
The Biotechnology Center of Excellence at Janssen discovers and develops protein-, peptide- and cell-based products that transform and improve patients’ lives.
We apply our industry leading biotechnology expertise and capabilities to a broad range of projects, working internally with our Therapeutic Areas and collaboratively across the Johnson & Johnson family of companies, and with external partners to realize the full potential of biotechnology and bring significant value to people living with disease and to our company.
Janssen is a leader in biopharmaceuticals as the 4th largest global biotech company driven by an industry-leading portfolio of biologic medicines. Our innovative biologic therapeutics platforms, and extensive expertise and capabilities in the discovery and development of biopharmaceuticals are enabling the creation of differentiated medicines to treat some of the most challenging diseases of our time.
